Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Free Cash Flow (2021 - 2025)

Core Scientific (CORZW) has disclosed Free Cash Flow for 5 consecutive years, with -$121.7 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 714.14% to -$121.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$450.8 million through Dec 2025, down 765.74% year-over-year, with the annual reading at -$450.8 million for FY2025, 765.74% down from the prior year.
  • Free Cash Flow hit -$121.7 million in Q4 2025 for Core Scientific, up from -$317.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $225.8 million in Q4 2021 to a low of -$317.9 million in Q3 2025.
  • Historically, Free Cash Flow has averaged -$31.6 million across 5 years, with a median of -$20.2 million in 2024.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 201.42% in 2022 and later tumbled 1148.71% in 2025.
  • Year by year, Free Cash Flow stood at $225.8 million in 2021, then crashed by 191.07% to -$205.7 million in 2022, then soared by 103.1% to $6.4 million in 2023, then plummeted by 334.3% to -$15.0 million in 2024, then crashed by 714.14% to -$121.7 million in 2025.
  • Business Quant data shows Free Cash Flow for CORZW at -$121.7 million in Q4 2025, -$317.9 million in Q3 2025, and $34.0 million in Q2 2025.